Baric Transcribed Interview (Redacted) — page 24

DC.Scheduling@LexitasLegal.com about whether it was with Wuhan Institute of Virology or not. Again, he would be the person you'd need to ask that of. MS. SALAZAR: And then going back real quick to the RO1 grant. You weren't an official collaborator, or PI, co-PI, until later on. But you did provide a letter of support -- DR. BARIC: Yes. MS. SALAZAR: -- for the initial grant in 2014. Is that right? DR. BARIC: Well, I may have. It wouldn't surprise me if I did. If he asked me, I would've, yes. MS. SALAZAR: Okay. And then did you provide any mouse models or anything like that prior to your involvement formally later on? DR. BARIC: To Peter? MS. SALAZAR: To Peter or to, with -- DR. BARIC: Okay. Around 2013 or 2014, Zhengli Shi identified two new sarbecoviruses called SHC014 and WIV1. She was able to culture WIV1 in cell culture, and they published a paper in Nature on that. And we met at a meeting and we had some discussions. Ultimately, she provided me with the sequences, and we used that, of the spike, going at the spike like a protein. And so we build chimeric viruses.